Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arena Pharmaceuticals Inc buy Biotechhunter

Start price
€50.50
28.05.20 / 50%
Target price
-
02.06.20
Performance (%)
21.78%
End price
€61.50
02.06.20
Summary
This prediction ended on 02.06.20 with a price of €61.50. The prediction had a final performance of 21.78%. Biotechhunter has 50% into this prediction

Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.

Performance without dividends (%)
Name 1w 1m 1y 3y
Arena Pharmaceuticals Inc - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by Biotechhunter for this prediction

In the thread Arena Pharmaceuticals Inc diskutieren

Buy Arena Pharmaceuticals Inc

In the thread Trading Arena Pharmaceuticals Inc
Prediction Buy
Perf. (%) 21.78%
Target price
Change
Ends at 02.06.20

Buy beendet

Stopped prediction by Biotechhunter for Arena Pharmaceuticals Inc

Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€52.50
31.07.20
-
04.11.21
4.76%
15.07.21

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€61.50
02.06.20
-
31.07.20
-14.63%
31.07.20